feed,title,long_url,short_url
Benzinga,"Regeneron's Dupixent COPD Sales To Reach $20B By 2026, Analyst Sees Larger Addressable Market",https://benzinga.com/markets/equities/24/06/39312759/regenerons-dupixent-copd-sales-to-reach-20b-by-2026-analyst-sees-larger-addressable-market,https://da.gd/sdP0
Benzinga,"Dogecoin Flat But 'Nice Little Bullish Chart' Bodes Well, Says Trader",https://benzinga.com/markets/cryptocurrency/24/06/39312757/dogecoin-flat-but-nice-little-bullish-chart-bodes-well-says-trader,https://da.gd/FdkOVE
